We are investigating the safety and effectiveness of sertraline (Zoloft), an antidepressant, in treating the depressive symptoms suffered specifically by people who have vascular dementia. In addition, we are using brain imaging to examine whether these clinical improvements can be associated with changes in brain anatomy and function.
Currently we are recruiting patients with vascular dementia and depression.
Your involvement in the study lasts about 12 weeks and consists of 5 study visits, during which you will:
Originally created: 12 Jan 2011 Current author: Tim Ando
Jane & Terry Semel Institute for Neuroscience & Human Behavior
760 Westwood Plaza
Los Angeles, CA 90095
UCLA Health System School of Medicine
(c) UC Regents 2011 Privacy Notice
Help Sitemap A-Z index